What type of study is this?

This is a In Vitro Study study (also classified as: Experimental Study).

September 19, 2025

Anticancer potential of Dendrocnide meyeniana: phytochemical profiling, ADMET analysis, molecular docking, and in silico cytotoxicity evaluation

View Full Paper

Ask AI

Bookmark

Authors

Research demonstrates phytochemical profiling and ADMET evaluation in dendrocnide meyeniana, suggesting significant anticancer activity.

Dendrocnide meyeniana exhibits strong anticancer potential, making it a promising candidate for drug development.
Among 78 identified phytochemicals, eight show favorable oral bioavailability, indicating good drug-likeness characteristics.
Molecular docking simulations reveal cryptotanshinone as a lead compound with better docking scores than traditional chemotherapeutics.
In silico cytotoxicity assessments highlight potential inhibitors for brain glioma and lymphoblastic leukemia cell lines from this plant.

Pooten et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

September 19, 2025

View Full Paper

Ask AI

Bookmark

Authors

Research demonstrates phytochemical profiling and ADMET evaluation in dendrocnide meyeniana, suggesting significant anticancer activity.

Dendrocnide meyeniana exhibits strong anticancer potential, making it a promising candidate for drug development.
Among 78 identified phytochemicals, eight show favorable oral bioavailability, indicating good drug-likeness characteristics.
Molecular docking simulations reveal cryptotanshinone as a lead compound with better docking scores than traditional chemotherapeutics.
In silico cytotoxicity assessments highlight potential inhibitors for brain glioma and lymphoblastic leukemia cell lines from this plant.

Pooten et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark